We-P11:49 Safety and efficacy of long-term (UP to 24 months) ezetimibe (EZE) therapy in hypercholesterolemic patients
Veltri, E.; Suresh, R.; Strony, J.
Atherosclerosis Suppls 7(3): 356-357
2006
DOI: 10.1016/s1567-5688(06)81405-4
Accession: 063528948
PDF emailed within 0-6 h: $19.90
Related References
Wiegman, A.; Hutten, B.A.; Degroot, E.; Rodenburg, J.; Bakker, H.D.; Buller, H.R.; Sijbrands, E.J.; Kastelein, J.J. 2003: Statin therapy in hypercholesterolemic children Long-term efficacy and safety Circulation 108(17): IV527Wiegman, A.; Hutten, B.A.; DeGroot, E.; Rodenburg, J.; Bakker, H.D.; Biller, H.R.; Sijbrands, E.J.G.; Kastelein, J.J.P. 2003: 3P-0913 Statin therapy in hypercholesterolemic children. Long-term efficacy and safety Atherosclerosis Suppls 4(2): 262-263
Teramoto, T.; Abe, K.; Taneyama, T. 2013: Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study Cardiovascular Diabetology 12: 163
Strony, J.; Yang, B.; Hanson, M.E.; Veltri, E.P. 2008: Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study Current Medical Research and Opinion 24(11): 3149-3157
Finlen Copeland, C.Ashley.; Davis, W.Austin.; Snyder, L.D.; Banks, M.; Avery, R.; Davis, R.Duane.; Palmer, S.M. 2011: Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 30(9): 990-996
Kokufu, I.; Yamamoto, M.; Noda, T.; Hiratsuka, M.; Nishikawa, H. 2016: Long-term safety and efficacy of bisphosphonate (BP) therapy for more than 24 months (M) in breast cancer (BC) patients (pts) with bone metastasis (BM) Journal of Clinical Oncology 23(16_Suppl): 816-816
Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. 2011: Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia International Angiology: a Journal of the International Union of Angiology 30(3): 295; Author Reply 296
Avellone, G.; Di Garbo, V.; Guarnotta, V.; Scaglione, R.; Parrinello, G.; Purpura, L.; Torres, D.; Campisi, D. 2010: Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia International Angiology: a Journal of the International Union of Angiology 29(6): 514-524
McKenney, J.M.; Farnier, M.; Lo, K.-W.; Bays, H.E.; Perevozkaya, I.; Carlson, G.; Davies, M.J.; Mitchel, Y.B.; Gumbiner, B. 2006: Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia Journal of the American College of Cardiology 47(8): 1584-1587
Farnier, M.; Retterstøl, K.; Steinmetz, A.; Császár, A. 2012: Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease Diabetes and Vascular Disease Research 9(3): 205-215
Robinson, J. G.; Davidson, M. H.; Shah, A.; Lin, J.; Neff, D.; DeLucca, P. T.; Tomassini, J. E.; Veltri, E.; Tershakovec, A. M. 2007: Efficacy and safety of ezetimibe and ezetimibe plus statin Therapy in patients aged under 65, 65–74 and 75 years and older Aging Health 3(6): 691-705
Kishimoto, M.; Sugiyama, T.; Osame, K.; Takarabe, D.; Okamoto, M.; Noda, M. 2011: Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes Journal of Medical Investigation: Jmi 58(1-2): 86-94
Fazio, S.; Guyton, J.R.; Polis, A.B.; Adewale, A.J.; Tomassini, J.E.; Ryan, N.W.; Tershakovec, A.M. 2010: Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia American Journal of Cardiology 105(4): 487-494
Oikawa, S.; Yamashita, S.; Nakaya, N.; Sasaki, J.; Kono, S. 2017: Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study Journal of Atherosclerosis and Thrombosis 24(1): 77-94
Guyton, J.R.; Fazio, S.; Polis, A.; Adewale, A.; Tomassini, J.E.; Tershakovec, A. 2009: Long-term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin+Extended-Release Niacin in Hyperlipidemic Patients Journal of Clinical Lipidology 3(3): 230-231
Lütjohann, D.; von Bergmann, K.; Sirah, W.; Macdonell, G.; Johnson-Levonas, A.O.; Shah, A.; Lin, J.; Sapre, A.; Musliner, T. 2008: Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study International Journal of Clinical Practice 62(10): 1499-1510
Park, H.; Shima, T.; Yamaguchi, K.; Mitsuyoshi, H.; Minami, M.; Yasui, K.; Itoh, Y.; Yoshikawa, T.; Fukui, M.; Hasegawa, G.; Nakamura, N.; Ohta, M.; Obayashi, H.; Okanoue, T. 2011: Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease Journal of Gastroenterology 46(1): 101-107
Fazio, S.; Guyton, J.R.; Lin, J.; Tomassini, J.E.; Shah, A.; Tershakovec, A.M. 2010: Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome Diabetes Obesity and Metabolism 12(11): 983-993
Kim, B.-K.; Hong, S.-J.; Lee, Y.-J.; Hong, S.J.; Yun, K.H.; Hong, B.-K.; Heo, J.H.; Rha, S.-W.; Cho, Y.-H.; Lee, S.-J.; Ahn, C.-M.; Kim, J.-S.; Ko, Y.-G.; Choi, D.; Jang, Y.; Hong, M.-K. 2022: Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial Lancet 400(10349): 380-390
Descamps, O.; Tomassini, J.E.; Lin, J.; Polis, A.B.; Shah, A.; Brudi, P.; Hanson, M.E.; Tershakovec, A.M. 2015: Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients Atherosclerosis 240(2): 482-489